"
Team:EPF-Lausanne/Our Project/TetR mutants/Conclusion
From 2011.igem.org
(Difference between revisions)
| Line 47: | Line 47: | ||
| normal | | normal | ||
|} | |} | ||
| + | |||
| + | The MITOMI results can be found [https://2011.igem.org/Team:EPF-Lausanne/Our_Project/TetR_mutants/MITOMI_data here]. The in vivo characterizations are on [https://2011.igem.org/Team:EPF-Lausanne/Our_Project/Reporter_Systems/tetR#TetR_mutant_characterization this page]. | ||
{{:Team:EPF-Lausanne/Templates/Footer}} | {{:Team:EPF-Lausanne/Templates/Footer}} | ||
Revision as of 02:53, 22 September 2011
Conclusion
In vitro Main | Why TetR? | Mutant TetRs | MITOMI Data | In-vivo & In-vitro outline
For some of the TetR mutants, we managed to have both an in vitro and in vivo characterization. The results are available in the table below.
| Mutant | Biobrick number | Affinity compared to WT - in vivo | Affinity compared to WT - MITOMI | ATC repression |
|---|---|---|---|---|
| V36F | BBa_K613013 | same | same | altered |
| V36F W43S | BBa_K613014 | same | not tested | altered |
| E37A W43S T141A | BBa_K613015 | same | altered | |
| P39K | BBa_K613016 | no affinity | normal | |
| Y42F K108E | BBa_K613018 | reduced | normal | |
| P39Q Y42M | BBa_K613019 | no affinity | not tested | normal |
The MITOMI results can be found here. The in vivo characterizations are on this page.
